Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 5/20 | 0.49 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | CTSK | P43235 | 2/20 | 0.44 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.43 |
| ▸ | MAOA | P21397 | 1/20 | 0.43 |
| ▸ | MAOB | P27338 | 1/20 | 0.43 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.41 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.41 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.41 |
| ▸ | PGAM1 | P18669 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Kazinol J SCHEMBL31238391 | 0.86 | ALOX5 (0.47) | ALOX5MAPTCYP19A1PTGS2PTPN1 | |
| Broussonin C SCHEMBL23268429 | 0.76 | HTT (0.50) | TYRALOX5MEN1TP53CYP3A4 | |
| Broussonin C SCHEMBL29369898 | 0.76 | HTT (0.50) | TYRALOX5MEN1TP53CYP3A4 | |
| SCHEMBL8698637 | 0.76 | TYR (0.54) | TYRALOX5MEN1CYP3A4HTT | |
| SCHEMBL28136635 | 0.75 | PTPN1 (0.49) | ALOX5MEN1TP53CYP3A4MAPT | |
| Kazinol C SCHEMBL14815139 | 0.74 | ACHE (0.43) | MEN1CYP3A4HTTKMT2ACYP19A1 | |
| SCHEMBL4370686 | 0.73 | TYR (0.81) | TYRALOX5MEN1TP53CYP3A4 | |
| SCHEMBL6819084 | 0.71 | MAPT (0.47) | TYRALOX5MEN1MAPTALOX15 | |
| SCHEMBL7898977 | 0.70 | CYP19A1 (0.55) | ALOX5MEN1CYP3A4HTTKMT2A | |
| SCHEMBL22579813 | 0.69 | MAPT (0.54) | ALOX5MAPTKMT2AMAOAMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023219526-A1 | MULTITARGET ANTIVIRAL DIETARY SUPPLEMENT | PROKIN MILAN (RS) | 2023-11-16 | — | — | WO | claimed |
| EP-4408435-B1 | COMPOSITION COMPRISING HESPERIDIN, CITRAL AND SODIUM ALGINATE AS A FILM-FORMING SUBSTANCE FOR PROPHYLAXIS OF INFECTIONS | MVS PHARMA GMBH (DE) | 2025-08-13 | — | — | EP | disclosed |
| EP-4408435-A1 | COMPOSITION COMPRISING HESPERIDIN, CITRAL AND A FILM-FORMING SUBSTANCE FOR PROPHYLAXIS OF INFECTIONS | MVS Pharma GmbH (DE) | 2024-08-07 | — | — | EP | disclosed |
| WO-2024135975-A1 | METHOD FOR PREPARING ENVIRONMENTALLY FRIENDLY PARTICLES DERIVED FROM POLYSACCHARIDE NANOFIBERS, AND ENVIRONMENTALLY FRIENDLY PARTICLES DERIVED FROM POLYSACCHARIDE NANOFIBERS | 주식회사 에이엔폴리 | 2024-06-27 | — | — | WO | disclosed |
| WO-2023219526-A1 | MULTITARGET ANTIVIRAL DIETARY SUPPLEMENT | PROKIN MILAN (RS) | 2023-11-16 | — | — | WO | disclosed |
| EP-3610865-B1 | COMPOSITION COMPRISING BENZOIC ACID AMIDE COMPOUND AND CYCLODEXTRIN SOLUBILIZING AGENT | AMOREPACIFIC CORP (KR) | 2023-07-12 | — | — | EP | disclosed |
| US-11654094-B2 | Composition comprising benzoic acid amide compound and cyclodextrin solubilizing agent | AMOREPACIFIC CORPORATION (KR) | 2023-05-23 | — | — | US | disclosed |
| WO-2023052310-A1 | COMPOSITION COMPRISING HESPERIDIN, CITRAL AND A FILM-FORMING SUBSTANCE FOR PROPHYLAXIS OF INFECTIONS | MSV PHARMA GMBH (DE) | 2023-04-06 | — | — | WO | disclosed |
| EP-4159208-A1 | COMPOSITIONS AND METHODS FOR THE PROPHYLAXIS OF AN INFECTION | MVS Pharma GmbH (DE) | 2023-04-05 | — | — | EP | disclosed |
| US-20210093532-A1 | COMPOSITION COMPRISING BENZOIC ACID AMIDE COMPOUND AND CYCLODEXTRIN SOLUBILIZING AGENT | AMOREPACIFIC CORPORATION (KR) | 2021-04-01 | — | — | US | disclosed |
| CN-105441230-A | Camellia oil cold processed soap | JIANGXI GOLDEN OIL TEA IND DEV CO LTD | 2016-03-30 | — | — | CN | disclosed |
| CN-102946894-B | Method for preparing broussonetia kazinoki extract | AMOREPACIFIC CORP. (KR) | 2014-10-15 | — | — | CN | disclosed |
| US-8722027-B2 | Method for preparing broussonetia kazinoki extract | AMOREPACIFIC CORPORATION (KR) | 2014-05-13 | — | — | US | disclosed |
| US-20130084258-A1 | METHOD FOR PREPARING BROUSSONETIA KAZINOKI EXTRACT | AMOREPACIFIC CORPORATION (KR) | 2013-04-04 | — | — | US | disclosed |
| CN-102946894-A | Method for preparing broussonetia kazinoki extract | AMOREPACIFIC CORP | 2013-02-27 | — | — | CN | disclosed |
| CN-100522193-C | Use of Broussonetia papyrifera red pigment | UNIV PLA 2ND MILITARY MEDICAL (CN) | 2009-08-05 | — | — | CN | disclosed |
| CN-1861118-A | Method for preparing Broussonetia papyrifera red pigment, and use thereof | UNIV PLA 2ND MILITARY MEDICAL (CN) | 2006-11-15 | — | — | CN | disclosed |
| CN-1229107-C | Skin whitening cosmetic containing acyl substituted glucose or sucrose derivative | LG HOUSEHOLD & HEALTHCARE CO L (KR) | 2005-11-30 | — | — | CN | disclosed |
| CN-1531416-A | Skin whitening cosmetic containing acyl substituted glucose or sucrose derivative | LG生活健康株式会社 | 2004-09-22 | — | — | CN | disclosed |
| WO-2002053121-A1 | COSMETIC FOR SKIN WHITENING CONTAINING ACYL SUBSTITUTED DERIVATIVES OF GLUCOSE OR SUCROSE | LG HOUSEHOLD & HEALTHCARE CO., LTD. (KR) | 2002-07-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210093532-A1 | COMPOSITION COMPRISING BENZOIC ACID AMIDE COMPOUND AND CYCLODEXTRIN SOLUBILIZING AGENT | CEL, ABCG2, TBCA | TYR 125/4885ALOX5 3355/4885MEN1 4795/4885 |
| US-11654094-B2 | Composition comprising benzoic acid amide compound and cyclodextrin solubilizing agent | CEL, ABCG2, TBCA | TYR 125/4885ALOX5 3355/4885MEN1 4795/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.